Compare · INSP vs MDLN
INSP vs MDLN
Side-by-side comparison of Inspire Medical Systems Inc. (INSP) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both INSP and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.40B, about 36.7x INSP ($1.21B).
- Over the past year, INSP is down 69.2% and MDLN is down 17.1% - MDLN leads by 52.1 points.
- MDLN has been more active in the news (20 items in the past 4 weeks vs 3 for INSP).
- Both have 25 recent analyst ratings on file.
- Company
- Inspire Medical Systems Inc.
- Medline Inc.
- Price
- $42.03+1.99%
- $33.80+0.58%
- Market cap
- $1.21B
- $44.40B
- 1M return
- -7.87%
- -19.55%
- 1Y return
- -69.20%
- -17.07%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NYSE
- NASDAQ
- IPO
- 2018
- 2025
- News (4w)
- 3
- 20
- Recent ratings
- 25
- 25
Inspire Medical Systems Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and Europe. It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. The company also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. Inspire Medical Systems, Inc. was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Latest INSP
- SEC Form SD filed by Inspire Medical Systems Inc.
- Inspire Medical Systems downgraded by BofA Securities with a new price target
- Officer Rondoni John sold $114,302 worth of shares (2,641 units at $43.28), decreasing direct ownership by 9% to 27,165 units (SEC Form 4)
- Officer Rondoni John sold $30,107 worth of shares (700 units at $43.01), decreasing direct ownership by 2% to 29,806 units (SEC Form 4)
- Amendment: SEC Form SCHEDULE 13G/A filed by Inspire Medical Systems Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Inspire Medical Systems Inc.
- Director Mccormick Shawn sold $31,536 worth of shares (696 units at $45.31) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 27,712 units (SEC Form 4)
- SEC Form 144 filed by Inspire Medical Systems Inc.
- SEC Form S-8 filed by Inspire Medical Systems Inc.
- Inspire Medical Systems Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)